Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""BLOOD donors"" wg kryterium: Temat


Tytuł :
Assessment of blood supply and usage pre- and during COVID-19 pandemic: A lesson from non-voluntary donation.
Autorzy :
Ogar CO; Hematology Unit, Department of Medical Laboratory Science, University of Calabar, Nigeria.
Okoroiwu HU; Hematology Unit, Department of Medical Laboratory Science, University of Calabar, Nigeria. Electronic address: .
Obeagu EI; Department of Medical Laboratory Science, Imo State University, Nigeria.
Etura JE; Hematology Unit, Department of Medical Laboratory Science, University of Calabar, Nigeria.
Abunimye DA; Hematology Unit, Department of Medical Laboratory Science, University of Calabar, Nigeria.
Pokaż więcej
Źródło :
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine [Transfus Clin Biol] 2021 Feb; Vol. 28 (1), pp. 68-72. Date of Electronic Publication: 2020 Oct 17.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Pandemics*
SARS-CoV-2*
Blood Donors/*statistics & numerical data
Blood Transfusion/*statistics & numerical data
Adolescent ; Adult ; Blood Donors/psychology ; Blood Donors/supply & distribution ; Blood Transfusion/economics ; Blood Transfusion/psychology ; Cross-Sectional Studies ; Family ; Female ; Hospitals, Teaching/statistics & numerical data ; Hospitals, Urban/statistics & numerical data ; Humans ; Male ; Middle Aged ; Motivation ; Nigeria ; Occupations ; Procedures and Techniques Utilization ; Remuneration ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Guidance for the procurement of COVID-19 convalescent plasma: differences between high- and low-middle-income countries.
Autorzy :
Bloch EM; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Goel R; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Division of Hematology/Oncology, Simmons Cancer Institute at SIU School of Medicine and Mississippi Valley Regional Blood Center, Springfield, Illinois, USA.
Wendel S; Hospital Sirio Libanês, São Paulo, Brazil.
Burnouf T; Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.; International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.
Al-Riyami AZ; Department of Hematology, Sultan Qaboos University Hospital, Muscat, Sultanate of Oman.
Ang AL; Blood Services Group, Health Sciences Authority, Singapore, Singapore.
DeAngelis V; Transfusion Medicine Dept, Udine University Hospital, Udine, Italy.
Dumont LJ; Vitalant Research Institute, Denver, CO, USA.; University of Colorado School of Medicine, Denver, CO, USA.; Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Land K; Vice President Clinical Services, Vitalant, Scottsdale, AZ, USA.; Department of Pathology, UT Health Science Center San Antonio, San Antonio, TX, USA.
Lee CK; Hong Kong Red Cross Blood Transfusion Service, Hong Kong, China, China.; King's Park Rise, Kowloon, China.
Oreh A; National Blood Transfusion Service, Department of Hospital Services, Federal Ministry of Health, Abuja, Nigeria.
Patidar G; Department of Transfusion Medicine, All India Institute of Medical Sciences, New Delhi, India.
Spitalnik SL; Department of Pathology & Cell Biology, Columbia University, New York, NY, USA.
Vermeulen M; The South African National Blood Service, Johannesbur, South Africa.
Hindawi S; Haematology & Transfusion Medicine, King Abdalaziz University, Jeddah, Saudi Arabia.
Van den Berg K; The South African National Blood Service, Johannesbur, South Africa.
Tiberghien P; Etablissement Français du Sang, Paris, France.
Vrielink H; Department Unit Transfusion Medicine, Sanquin Blood Supply Foundation, Amsterdam, NL, Netherlands.
Young P; American Red Cross, Washington, D.C, USA.
Devine D; Canadian Blood Services, Vancouver, BC, Canada.; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
So-Osman C; Department Unit Transfusion Medicine, Sanquin Blood Supply Foundation, Amsterdam, NL, Netherlands.; Department of Haematology, Erasmus Medical Center, Rotterdam, NL, Netherlands.
Pokaż więcej
Źródło :
Vox sanguinis [Vox Sang] 2021 Jan; Vol. 116 (1), pp. 18-35. Date of Electronic Publication: 2020 Jul 20.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
COVID-19/*therapy
Developing Countries ; Guidelines as Topic ; Health Care Surveys ; Humans ; Immunization, Passive ; SARS-CoV-2
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Iron deficiency among French whole-blood donors: first assessment and identification of predictive factors.
Autorzy :
Fillet AM; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Martinaud C; Centre de Transfusion Sanguine des Armées, Clamart, France.
Malard L; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Le Cam S; Etablissent Français du sang, Blood Biological Qualification, Angers, France.
Hejl C; Laboratory Medicine Department, Military Medical Center Percy, Clamart, France.
Chenus F; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Woimant G; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Chueca M; Centre de Transfusion Sanguine des Armées, Clamart, France.
Jacquot E; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Besiers C; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Morel P; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Djoudi R; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Garrabé E; Centre de Transfusion Sanguine des Armées, Clamart, France.
Gross S; Etablissement Français du Sang, La Plaine Saint-Denis, France.
Pokaż więcej
Źródło :
Vox sanguinis [Vox Sang] 2021 Jan; Vol. 116 (1), pp. 42-52. Date of Electronic Publication: 2020 Sep 23.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Blood Donors*
Ferritins/*blood
Hemoglobins/*analysis
Iron/*deficiency
Female ; France ; Humans ; Male ; Middle Aged ; Prevalence ; Prospective Studies
Czasopismo naukowe
Tytuł :
Comment on "Delayed adverse events in male plateletpheresis donors: Initial insights on donor safety".
Autorzy :
Mukherjee S; Department of Transfusion Medicine, All India Institute of Medical Sciences, Bhubaneswar, India.
Prakash S; Department of Transfusion Medicine, All India Institute of Medical Sciences, Bhubaneswar, India.
Pokaż więcej
Źródło :
Journal of clinical apheresis [J Clin Apher] 2021 Feb; Vol. 36 (1), pp. 221-222. Date of Electronic Publication: 2020 Sep 24.
Typ publikacji :
Letter; Comment
MeSH Terms :
Blood Donors*
Plateletpheresis*
Humans ; Male
Opinia redakcyjna
Tytuł :
The impact of COVID-19 pandemic on blood supplies and transfusion services in Eastern Mediterranean Region.
Autorzy :
Al-Riyami AZ; Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman. Electronic address: .
Abdella YE; Regional office for the Eastern Mediterranean, World Health Organization, Cairo, Egypt. Electronic address: .
Badawi MA; King Abdulaziz University, Jeddah, Saudi Arabia; King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Electronic address: .
Panchatcharam SM; Oman Medical Specialty Board, Muscat, Oman. Electronic address: .
Ghaleb Y; National Blood Transfusion and Research Center, Sana'a, Yemen. Electronic address: .
Maghsudlu M; Blood Transfusion Research Center, High Institution for Research and Education in Transfusion Medicine, Tehran, Iran. Electronic address: .
Satti M; Department of Pathology, Faculty of Medicine, University of Khartoum, Khartoum, Sudan. Electronic address: .
Lahjouji K; National Blood Transfusion and Hematology, Rabat, Morocco. Electronic address: .
Merenkov Z; Transfusion Medicine and Laboratory Information Systems, Hamad Medical Corporation, Doha, Qatar. Electronic address: .
Adwan A; Ministry of health, Amman, Jordan. Electronic address: .
Feghali R; Department of Laboratory Medicine, Rafik-Hariri University Hospital, Beirut, Lebanon. Electronic address: .
Gebril N; National Blood Services, Tripoli, Libya. Electronic address: .
Hejress S; Blood Bank and Laboratory Medicine, Department of Pathology, King Hamad University Hospital & Bahrain Oncology Centre, Al-Sayh, Bahrain. Electronic address: .
Hmida S; National Blood Transfusion Centre of Tunis, Tunis, Tunisia. Electronic address: .
AlHumaidan H; Department of Pathology & Laboratory Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia. Electronic address: .
Jamal D; Sindh Blood Transfusion Authority, Karachi, Pakistan. Electronic address: .
Najjar O; Palestinian Ministry of Health, Ramallah, Palestine. Electronic address: .
Raouf M; Dubai Blood Donation Centre, Dubai Health Authority, Dubai, United Arab Emirates. Electronic address: .
Pokaż więcej
Źródło :
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine [Transfus Clin Biol] 2021 Feb; Vol. 28 (1), pp. 16-24. Date of Electronic Publication: 2020 Dec 01.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*/prevention & control
Pandemics*
SARS-CoV-2*
Blood Banks/*statistics & numerical data
Blood Donors/*supply & distribution
Blood Transfusion/*statistics & numerical data
Africa, Northern ; Blood Banks/organization & administration ; Blood Donors/psychology ; Donor Selection/standards ; Health Care Surveys ; Hematologic Neoplasms/therapy ; Hemoglobinopathies/therapy ; Humans ; Infection Control/organization & administration ; Infectious Disease Transmission, Patient-to-Professional/prevention & control ; Infectious Disease Transmission, Professional-to-Patient/prevention & control ; Mediterranean Region ; Middle East ; Pakistan ; Professional-Patient Relations
Czasopismo naukowe
Tytuł :
What is the optimal usage of coronavirus disease 2019 convalescent plasma donations?
Autorzy :
Focosi D; North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy. Electronic address: .
Tuccori M; Division of Pharmacovigilance, Pisa University Hospital, Pisa, Italy.
Antonelli G; Laboratory of 'Microbiology and Virology', Department of Molecular Medicine, University Hospital 'Policlinico Umberto I' Sapienza University, Rome, Italy.
Maggi F; Division of Virology, University of Pisa, Pisa, Italy.
Pokaż więcej
Źródło :
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2021 Feb; Vol. 27 (2), pp. 163-165. Date of Electronic Publication: 2020 Sep 29.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
Plasma*
COVID-19/*therapy
COVID-19/economics ; Clinical Trials as Topic ; Humans ; Immunization, Passive/economics ; Immunization, Passive/standards
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates.
Autorzy :
Boonyaratanakornkit J; Department of Medicine, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Seattle Cancer Care Alliance, Seattle, Washington, USA.
Morishima C; Department of Laboratory Medicine and Pathology, and.
Selke S; Department of Laboratory Medicine and Pathology, and.
Zamora D; Department of Medicine, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
McGuffin S; Department of Medicine, University of Washington, Seattle, Washington, USA.
Shapiro AE; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA.
Campbell VL; Department of Medicine, University of Washington, Seattle, Washington, USA.
McClurkan CL; Department of Medicine, University of Washington, Seattle, Washington, USA.
Jing L; Department of Medicine, University of Washington, Seattle, Washington, USA.
Gross R; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Frederick, Maryland, USA.
Liang J; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Frederick, Maryland, USA.
Postnikova E; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Frederick, Maryland, USA.
Mazur S; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Frederick, Maryland, USA.
Lukin VV; Kearney, Chicago, Illinois, USA.
Chaudhary A; Department of Laboratory Medicine and Pathology, and.
Das MK; Department of Laboratory Medicine and Pathology, and.
Fink SL; Department of Laboratory Medicine and Pathology, and.
Bryan A; Department of Laboratory Medicine and Pathology, and.
Greninger AL; Department of Laboratory Medicine and Pathology, and.
Jerome KR; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, and.
Holbrook MR; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Frederick, Maryland, USA.
Gernsheimer TB; Department of Medicine, University of Washington, Seattle, Washington, USA.; Seattle Cancer Care Alliance, Seattle, Washington, USA.
Wener MH; Department of Medicine, University of Washington, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, and.
Wald A; Department of Medicine, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA.
Koelle DM; Department of Medicine, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, and.; Department of Global Health, University of Washington, Seattle, Washington, USA.; Benaroya Research Institute, Seattle, Washington, USA.
Pokaż więcej
Źródło :
The Journal of clinical investigation [J Clin Invest] 2021 Feb 01; Vol. 131 (3).
Typ publikacji :
Clinical Trial; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Antibodies, Neutralizing*/blood
Antibodies, Neutralizing*/immunology
Antibodies, Viral*/blood
Antibodies, Viral*/immunology
Blood Donors*
Immunoglobulin G*/blood
Immunoglobulin G*/immunology
SARS-CoV-2*/immunology
SARS-CoV-2*/metabolism
COVID-19/*therapy
Adult ; Aged ; Aged, 80 and over ; COVID-19/blood ; COVID-19/immunology ; Female ; Humans ; Immunization, Passive ; Male ; Middle Aged
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Post-donation information and haemovigilance reporting for COVID-19 in Greece: Information supporting the absence of SARS-CoV-2 possible transmission through blood components.
Autorzy :
Politis C; Coordinating Centre for Haemovigilance and Surveillance of Transfusion, Hellenic National Public Health Organization,, Athens, Greece. Electronic address: .
Papadaki M; Blood transfusion service, Sotiria thoracic diseases hospital of Athens, Athens, Greece.
Politi L; Laboratory of microbiology, medical school, National and Kapodistrian University of Athens, Athens, Greece.
Kourti G; Haematology department, Sotiria thoracic diseases hospital of Athens, Athens, Greece.
Richardson C; Panteion university of social and political sciences, Athens, Greece.
Asariotou M; Coordinating Centre for Haemovigilance and Surveillance of Transfusion, Hellenic National Public Health Organization,, Athens, Greece.
Tsakris A; Laboratory of microbiology, medical school, National and Kapodistrian University of Athens, Athens, Greece.
Mentis A; Public health laboratories, Hellenic Pasteur Institute, Athens, Greece.
Pokaż więcej
Źródło :
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine [Transfus Clin Biol] 2021 Feb; Vol. 28 (1), pp. 55-59. Date of Electronic Publication: 2020 Oct 20.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Blood Donors*
Blood Safety*
Pandemics*
Blood Component Transfusion/*adverse effects
COVID-19/*transmission
Donor Selection/*standards
SARS-CoV-2/*isolation & purification
Viremia/*transmission
Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Asymptomatic Infections ; COVID-19/blood ; COVID-19/diagnosis ; COVID-19/prevention & control ; COVID-19 Testing ; Contact Tracing ; Female ; Greece/epidemiology ; Humans ; Immunocompromised Host ; Leukemia, Myeloid, Acute/drug therapy ; Leukemia, Myeloid, Acute/therapy ; Male ; Middle Aged ; Platelet-Rich Plasma ; Police ; Viremia/blood ; Viremia/diagnosis
Czasopismo naukowe
Tytuł :
Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses.
Autorzy :
Schlickeiser S; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Berlin Institute of Health Center for Regenerative Therapies (BCRT), Charité - Universitätsmedizin Berlin, Berlin, Germany.
Schwarz T; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Institute of Virology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, and German Centre for Infection Research (DZIF), Partner Site Charité, Berlin, Germany.
Steiner S; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Wittke K; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Al Besher N; Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Meyer O; Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Kalus U; Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Pruß A; Institute of Transfusion Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Kurth F; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Zoller T; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Witzenrath M; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; German Center for Lung Research (DZL), Partner Site Charité, Berlin, Germany.
Sander LE; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; German Center for Lung Research (DZL), Partner Site Charité, Berlin, Germany.
Müller MA; Institute of Virology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, and German Centre for Infection Research (DZIF), Partner Site Charité, Berlin, Germany.
Scheibenbogen C; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Volk HD; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Berlin Institute of Health Center for Regenerative Therapies (BCRT), Charité - Universitätsmedizin Berlin, Berlin, Germany.; Berlin Center for Advanced Therapies (BeCAT), Charité - Universitätsmedizin Berlin, Berlin, Germany.
Drosten C; Institute of Virology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, and German Centre for Infection Research (DZIF), Partner Site Charité, Berlin, Germany.
Corman VM; Institute of Virology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, and German Centre for Infection Research (DZIF), Partner Site Charité, Berlin, Germany.
Hanitsch LG; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 Jan 29; Vol. 11, pp. 628971. Date of Electronic Publication: 2021 Jan 29 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
Antibodies, Neutralizing/*immunology
Antibodies, Viral/*immunology
COVID-19/*immunology
COVID-19/*therapy
Adolescent ; Adult ; Age Factors ; Aged ; Convalescence ; Female ; Fever ; Humans ; Immunization, Passive ; Male ; Middle Aged ; SARS-CoV-2/immunology ; Severity of Illness Index ; Sex Factors ; Young Adult
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors.
Autorzy :
Erikstrup C; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine Aarhus University, Aarhus, Denmark.
Hother CE; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
Pedersen OBV; Department of Clinical Immunology, Zealand University Hospital, Naestved, Denmark.
Mølbak K; Infection Control, Statens Serum Institut, Copenhagen, Denmark.
Skov RL; Infection Control, Statens Serum Institut, Copenhagen, Denmark.
Holm DK; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Sækmose SG; Department of Clinical Immunology, Zealand University Hospital, Naestved, Denmark.
Nilsson AC; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Brooks PT; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
Boldsen JK; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine Aarhus University, Aarhus, Denmark.
Mikkelsen C; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Gybel-Brask M; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
Sørensen E; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
Dinh KM; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine Aarhus University, Aarhus, Denmark.
Mikkelsen S; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine Aarhus University, Aarhus, Denmark.
Møller BK; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine Aarhus University, Aarhus, Denmark.
Haunstrup T; Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark.
Harritshøj L; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
Jensen BA; Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark.
Hjalgrim H; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
Lillevang ST; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Ullum H; Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jan 27; Vol. 72 (2), pp. 249-253.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
COVID-19*
Adolescent ; Adult ; Aged ; Antibodies, Viral ; Humans ; Middle Aged ; SARS-CoV-2 ; Seroepidemiologic Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Epidemiological survey and screening strategy for dengue virus in blood donors from Yunnan Province.
Autorzy :
Li L; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Chengdu, China.; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, China.
Li Y; Xishuangbanna Blood Center, Xishuangbanna, China.
Lu S; Xishuangbanna Blood Center, Xishuangbanna, China.
Dong J; Xishuangbanna Blood Center, Xishuangbanna, China.
Xu H; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Chengdu, China.; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, China.
Zhang Q; Xishuangbanna Blood Center, Xishuangbanna, China.
Weng R; Xishuangbanna Blood Center, Xishuangbanna, China.
Yin Y; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Chengdu, China.; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, China.
He R; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Chengdu, China.; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, China.
Fang P; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Chengdu, China.; Anhui Medical University, Hefei, China.
Shi H; Xishuangbanna Blood Center, Xishuangbanna, China.
Yu Y; Xishuangbanna Blood Center, Xishuangbanna, China.
Wu J; Xishuangbanna Blood Center, Xishuangbanna, China. .
Liu Z; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Chengdu, China. .; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, China. .
Hess JR; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, USA.
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Jan 22; Vol. 21 (1), pp. 104. Date of Electronic Publication: 2021 Jan 22.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
Dengue/*diagnosis
Dengue/*epidemiology
Dengue Virus/*isolation & purification
Mass Screening/*methods
Adult ; Antibodies, Viral/blood ; China/epidemiology ; Dengue/blood ; Dengue Virus/genetics ; Dengue Virus/immunology ; Female ; Humans ; Male ; Mass Screening/statistics & numerical data ; Middle Aged ; Prevalence ; RNA, Viral/genetics ; Viral Nonstructural Proteins/genetics ; Young Adult
Czasopismo naukowe
Tytuł :
Molecular characteristics of HBV infection among blood donors tested HBsAg reactive in a single ELISA test in southern China.
Autorzy :
Ye X; Shenzhen Blood Center, Meigang South Road, Shenzhen, 518000, P. R. China.
Li T; Shenzhen Blood Center, Meigang South Road, Shenzhen, 518000, P. R. China.
Li R; Shenzhen Blood Center, Meigang South Road, Shenzhen, 518000, P. R. China.
Liu H; Shenzhen Blood Center, Meigang South Road, Shenzhen, 518000, P. R. China.
Zhao J; Shenzhen Blood Center, Meigang South Road, Shenzhen, 518000, P. R. China. .; Department of Transfusion, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Jiefang Load 88, Hangzhou, 310000, P. R. China. .
Zeng J; Shenzhen Blood Center, Meigang South Road, Shenzhen, 518000, P. R. China. .
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Jan 19; Vol. 21 (1), pp. 83. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
Hepatitis B*
Hepatitis B Surface Antigens/*blood
Hepatitis B virus/*genetics
China ; DNA, Viral/genetics ; Enzyme-Linked Immunosorbent Assay ; Humans ; Nucleic Acid Amplification Techniques ; Phylogeny ; Polymerase Chain Reaction/methods
Czasopismo naukowe
Tytuł :
Syncopal-type reactions tend to be delayed and result in falls among elderly blood donors.
Autorzy :
Namba N; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.
Ishimaru F; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.
Kondo G; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.
Hashizume T; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.
Kunii N; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.
Shibata R; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.
Sawamura Y; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.
Kato T; Japanese Red Cross Tokyo Metropolitan Blood Center, Tokyo, Japan.
Pokaż więcej
Źródło :
Vox sanguinis [Vox Sang] 2021 Jan; Vol. 116 (1), pp. 36-41. Date of Electronic Publication: 2020 Jul 23.
Typ publikacji :
Journal Article
MeSH Terms :
Accidental Falls*
Blood Donors*
Syncope*
Adolescent ; Adult ; Age Factors ; Aged ; Female ; Humans ; Japan ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Sex Factors ; Young Adult
Czasopismo naukowe
Tytuł :
HIV incidence in South African blood donors from 2012 to 2016: a comparison of estimation methods.
Autorzy :
Vermeulen M; The South African National Blood Service, Roodepoort, South Africa.
Chowdhury D; Research Triangle Institute, Rockville, MD, USA.
Swanevelder R; The South African National Blood Service, Roodepoort, South Africa.
Grebe E; Vitalant Research Institute, San Francisco, CA, USA.
Brambilla D; Research Triangle Institute, Rockville, MD, USA.
Jentsch U; The South African National Blood Service, Roodepoort, South Africa.
Busch M; Vitalant Research Institute, San Francisco, CA, USA.
Van Zyl G; Stellenbosch University, Cape Town, South Africa.
Murphy EL; Vitalant Research Institute, San Francisco, CA, USA.; University of California San Francisco, San Francisco, CA, USA.
Pokaż więcej
Corporate Authors :
REDS-III International Program South Africa
Źródło :
Vox sanguinis [Vox Sang] 2021 Jan; Vol. 116 (1), pp. 71-80. Date of Electronic Publication: 2020 Aug 06.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
HIV Infections/*epidemiology
Adolescent ; Adult ; Female ; Humans ; Incidence ; Male ; South Africa/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
COVID-19 Convalescent Plasma: from donation to treatment - A Systematic Review & Single Center Experience.
Autorzy :
Fabricius MM; Medical Student, University of Missouri-Columbia, Columbia, Missouri.
Dandachi D; Assistant Professor of Clinical Medicine, Medical Director, Outpatient Parenteral Antimicrobial Therapy (OPAT) and Vascular Access, and Medical Director, HIV/AIDS Program, University of Missouri-Columbia, Columbia, Missouri.
Pokaż więcej
Źródło :
Missouri medicine [Mo Med] 2021 Jan-Feb; Vol. 118 (1), pp. 74-80.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Blood Donors/*supply & distribution
COVID-19/*therapy
Immunization, Passive/*methods
Adult ; Aged ; Aged, 80 and over ; Blood Donors/statistics & numerical data ; COVID-19/diagnosis ; COVID-19/epidemiology ; COVID-19/virology ; Donor Selection/methods ; Female ; Humans ; Male ; Middle Aged ; SARS-CoV-2/genetics ; SARS-CoV-2/isolation & purification ; Treatment Outcome
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Should individuals who have been cured of hepatitis C virus and their partners be allowed to donate blood?
Autorzy :
Aghemo A; Division of Internal Medicine and Hepatology, Department of Gastroenterology, Humanitas Clinical and Research Center IRCCS, Rozzano, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Valenti L; Department of Transfusion Medicine and Hematology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan 20122, Italy; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Viganò M; Hepatology Unit, Ospedale San Giuseppe, Milan, Italy.
Masetti C; Division of Internal Medicine and Hepatology, Department of Gastroenterology, Humanitas Clinical and Research Center IRCCS, Rozzano, Italy.
Rumi MG; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy; Hepatology Unit, Ospedale San Giuseppe, Milan, Italy.
Prati D; Department of Transfusion Medicine and Hematology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan 20122, Italy. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Haematology [Lancet Haematol] 2021 Jan; Vol. 8 (1), pp. e8-e10. Date of Electronic Publication: 2020 Dec 22.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
Hepatitis C/*pathology
Family Characteristics ; Female ; Hepacivirus/genetics ; Hepacivirus/isolation & purification ; Hepatitis C/virology ; Humans ; Male ; RNA, Viral/metabolism
Czasopismo naukowe
Tytuł :
Blood Is Life.
Autorzy :
Chimba R; 1Selian Lutheran Hospital, Arusha, Tanzania.
Quadri NS; 2Allina Health, Minneapolis, Minnesota.
Pokaż więcej
Źródło :
The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2021 Jan; Vol. 104 (1), pp. 5-6.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Banks*
Blood Donors*
Blood Transfusion*
Child, Preschool ; Humans ; Male ; National Health Programs ; Tanzania
Czasopismo naukowe
Tytuł :
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors.
Autorzy :
Uyoga S; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya. .
Adetifa IMO; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
Karanja HK; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Nyagwange J; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Tuju J; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Wanjiku P; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Aman R; Ministry of Health, Government of Kenya, Nairobi, Kenya.
Mwangangi M; Ministry of Health, Government of Kenya, Nairobi, Kenya.
Amoth P; Ministry of Health, Government of Kenya, Nairobi, Kenya.
Kasera K; Ministry of Health, Government of Kenya, Nairobi, Kenya.
Ng'ang'a W; Presidential Policy and Strategy Unit, The Presidency, Government of Kenya, Nairobi, Kenya.
Rombo C; Kenya National Blood Transfusion Services, Ministry of Health, Nairobi, Kenya.
Yegon C; Kenya National Blood Transfusion Services, Ministry of Health, Nairobi, Kenya.
Kithi K; Kenya National Blood Transfusion Services, Ministry of Health, Nairobi, Kenya.
Odhiambo E; Kenya National Blood Transfusion Services, Ministry of Health, Nairobi, Kenya.
Rotich T; Kenya National Blood Transfusion Services, Ministry of Health, Nairobi, Kenya.
Orgut I; Kenya National Blood Transfusion Services, Ministry of Health, Nairobi, Kenya.
Kihara S; Kenya National Blood Transfusion Services, Ministry of Health, Nairobi, Kenya.
Otiende M; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Bottomley C; Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
Mupe ZN; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Kagucia EW; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Gallagher KE; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
Etyang A; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Voller S; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
Gitonga JN; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Mugo D; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Agoti CN; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Otieno E; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Ndwiga L; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Lambe T; Nuffield Department of Medicine, Oxford University, Oxford, UK.
Wright D; Nuffield Department of Medicine, Oxford University, Oxford, UK.
Barasa E; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Tsofa B; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Bejon P; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Nuffield Department of Medicine, Oxford University, Oxford, UK.
Ochola-Oyier LI; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Agweyu A; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Scott JAG; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
Warimwe GM; KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.; Nuffield Department of Medicine, Oxford University, Oxford, UK.
Pokaż więcej
Źródło :
Science (New York, N.Y.) [Science] 2021 Jan 01; Vol. 371 (6524), pp. 79-82. Date of Electronic Publication: 2020 Nov 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Blood Donors*
Antibodies, Viral/*blood
COVID-19/*epidemiology
Immunoglobulin G/*blood
Adolescent ; Adult ; Aged ; Communicable Disease Control ; Humans ; Kenya/epidemiology ; Middle Aged ; SARS-CoV-2/physiology ; Seroepidemiologic Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Convalescent Whole Blood Donors Screening Strategies for Providing Efficient and Safe COVID-19 Survivors' Plasma and Other Blood Components.
Autorzy :
Mandel M; Blood Bank, Sheba Medical Center, Tel Hashomer, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Gurevich M; Neuroimmune Laboratory, Sheba Medical Center, Tel Hashomer, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Mandelboim M; Central Virology Laboratory, Sheba Medical Center, Tel Hashomer, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Amital H; Department of Medicine B, Sheba Medical Center, Tel Hashomer, Israel.; Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Achiron A; Neuroimmune Laboratory, Sheba Medical Center, Tel Hashomer, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Pokaż więcej
Źródło :
The Israel Medical Association journal : IMAJ [Isr Med Assoc J] 2021 Jan; Vol. 23 (1), pp. 7-10.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
Donor Selection*
COVID-19/*blood
SARS-CoV-2/*immunology
Adult ; Antibodies, Viral/immunology ; COVID-19/immunology ; Female ; Humans ; Immunization, Passive/methods ; Immunoglobulin G/blood ; Male ; Middle Aged ; RNA, Viral/blood ; Reverse Transcriptase Polymerase Chain Reaction ; SARS-CoV-2/isolation & purification ; Survivors ; Young Adult
Czasopismo naukowe
Tytuł :
Comparative Analysis of Rapid Test and Enzyme Linked Immunosorbent Assay for Screening of Blood Donors for Hepatitis B Surface Antigen Seropositivity.
Autorzy :
Adeleke AS; Department of Biomedical Laboratory Science, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Fasola FA; Department of Haematology, College of Medicine, University of Ibadan, University College Hospital, Ibadan, Nigeria.
Fowotade A; Department of Medical microbiology & Parasitology, College of Medicine, University of Ibadan, University College Hospital, Ibadan, Nigeria.
Pokaż więcej
Źródło :
West African journal of medicine [West Afr J Med] 2021 Jan; Vol. 38 (1), pp. 19-23.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Donors*
Enzyme-Linked Immunosorbent Assay*
Hepatitis B*/diagnosis
Hepatitis B*/epidemiology
Hepatitis B Surface Antigens*
DNA, Viral ; Hepatitis B virus ; Humans
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies